| Authors: |
Petersen DN; Medicine Design, Worldwide Research & Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA., Hawkins J; Cardiovascular and Metabolic Diseases Research Unit, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA., Ruangsiriluk W; Cardiovascular and Metabolic Diseases Research Unit, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA., Stevens KA; Cardiovascular and Metabolic Diseases Research Unit, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA., Maguire BA; Medicine Design, Worldwide Research & Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA., O'Connell TN; Medicine Design, Worldwide Research & Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA., Rocke BN; Medicine Design, Worldwide Research & Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA., Boehm M; Medicine Design, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA., Ruggeri RB; Medicine Design, Worldwide Research & Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA., Rolph T; Cardiovascular and Metabolic Diseases Research Unit, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA., Hepworth D; Medicine Design, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA., Loria PM; Medicine Design, Worldwide Research & Development, Pfizer, Inc., Eastern Point Road, Groton, CT 06340, USA. Electronic address: paula.m.loria@pfizer.com., Carpino PA; Medicine Design, Worldwide Research & Development, Pfizer, Inc., 610 Main Street, Cambridge, MA 02139, USA. Electronic address: philip.a.carpino@pfizer.com. |
